
CAS: 943609-66-3
Sort by
Found 2 products.
Vedolizumab
CAS:Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of Crohn's disease and ulcerative colitis.Purity:SDS-PAGE:98.4%;SEC-HPLC:99.1%Color and Shape:LiquidMolecular weight:146.80 kDaVedolizumab
CAS:Inhibits lymphocyte adhesion to mucosal endothelium; Crohn's disease therapyPurity:Min. 95%